The Shanghai Stock Exchange announced the List of Hong Kong Stock Connect Stocks under the Shanghai-Hong Kong Stock Connect recently. Six biomedicine enterprises in SIP are on the list.
The Shanghai-Hong Kong Stock Connect programme connects the Shanghai Stock Exchange and the Hong Kong Stock Exchange by allowing investors in each market to trade authorized shares on the other market, using their local brokers and clearing houses.
The six SIP-based enterprises include Suzhou Kintor Pharmaceutical Inc, Ascentage Pharma, CStone Pharmaceutical, Alphamab Oncology, Sirnaomics (Suzhou) and Peijia Medical.
March 13, 2023
